"The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."
NYS Entity Status
NYS Filing Date
APRIL 08, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - O'FARRILL LANDSCAPING & SNOW PLOWING, INC.
Around the Web
- Ryder Trucks Launches Campaign With 'Inc.'
Tuesday Sep 19, 2017
- The Snow Leopard Is No Longer Endangered. It’s Still at Risk.
By CHRISTINE HAUSER - Friday Sep 15, 2017
The animals have been reclassified as vulnerable by a leading conservationist group, but poaching and habitat loss still threaten their populations.
- Merriam-Webster gets spicy and political with new dictionary words
By Gianluca Mezzofiore - Tuesday Sep 19, 2017
Our favorite dictionary-turned-Twitter-wise-guy is back with fresh insights into our crazy, crazy times.
Merriam-Webster is expanding its vocabulary list with over 250 new words and definitions. While some of them reflect outstanding technological and societal changes, others seem to hint at how messed up our post-Trump era has become.
Two of the new words included in the dictionary's recent additions are "alt-right" and "troll," which complete each other and are a sad commentary on once-fringe movements going mainstream. Read more...More about Troll, Sriracha, Alt Right, Merriam Webster, and Merriam Webster Dictionary
- The South Park Commons Fills a Hole in the Tech Landscape
By CADE METZ - Sunday Jul 2, 2017
The Bay Area tech scene has start-up incubators and hacker spaces. But what do you do when you want to figure out your next move?
- Retailers Experiment With a New Philosophy: Smaller Is Better
By TIFFANY HSU - Saturday Nov 18, 2017
Department stores and other retailers struggling to beat back e-commerce are taking cues from online start-ups by experimenting with small showrooms.
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.